Paul Pfeiffer joined Cardinal Biologicals as President and CEO in February 2019. Prior to Cardinal Biologicals, he was a part-time faculty member at Southeast Missouri State University and held a number of leadership positions in the pharmaceutical and toxicology industries. Most recently he served as Area Sales Manager with Aegis Sciences Corporation, where he spent the previous nine years. He earned his BA in Communications from Maryville University and his MBA from Webster University, both in St. Louis, Missouri.
President & CEOpaul.firstname.lastname@example.org
Derek Yarbro has been with Cardinal Biologicals since 2014. He was promoted to Operations and Lab Manager in February 2019. Prior to Cardinal, Derek spent several years working in the clinical lab industry, primarily in the hospital setting. He is a registered and certified phlebotomist and member of the AACC.
Operations & Laboratory Managerderek.email@example.com
George “Skip” Wrape Jr. is co-founder and director of Cardinal Biologicals. He has a Bachelor of Science in Business Administration from Regis University in Denver, Colorado. His background is in providing quality raw biological materials for research, diagnostic, pharmaceutical, and educational purposes. He has been involved in the raw biological industry since 1980. Companies he co-owns or founded include Animal Technologies Incorporated, River City Biologicals Incorporated, and River City Brazil.
George "Skip" Wrape Jr.
Co-Founder & Director
Syed Rehan joined Cardinal Biologicals, Inc. as our Chief Science Officer and Board Member in April, 2020. Rehan is Founder and CEO of Molecular Biologicals International, Inc. (www.growcells.com) as well as co-founder and President of Tri-Forest products. Rehan graduated with his B.S. in Genetics from the University of Illinois in 1985. He was a PhD candidate at the University from 1985-1988 and he received his MBA from California State University – San Marcos in December 1997. Rehan brings over 30 years experience to Cardinal and his passion for research and development has been well recognized in our industry. In addition to spearheading research, he has pivotal in our business development efforts as well.
Chief Science Officer and Board Memberbizdev@cardinalbiologicals.com
Dana joined Cardinal Biologicals as Finance Director in February 2019. She also has a leadership role in River City Biologicals, Inc. and has held that position since 2014.